Agnieszka Wozniak
Lodz, LD 91347, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia.
Journal: International journal of molecular sciences
Published: September 10, 2025
Changes in lipoprotein(a) concentrations in patients with acute coronary syndrome.
Journal: Polish archives of internal medicine
Published: March 04, 2025
Lipoprotein(a) is associated with DNA damage in patients with heterozygous familial hypercholesterolemia.
Journal: Scientific reports
Published: December 15, 2023
OxLDL as a prognostic biomarker of plaque instability in patients qualified for carotid endarterectomy.
Journal: Journal of cellular and molecular medicine
Published: November 03, 2023
Severe COVID-19 classified by simple covid risk index is associated with higher levels of advanced oxidation protein products and 8-hydroxy 2 deoxyguanosine.
Journal: Epidemiology and infection
Published: August 09, 2023
Genotoxic Mechanism of Action of TBBPA, TBBPS and Selected Bromophenols in Human Peripheral Blood Mononuclear Cells.
Journal: Frontiers in immunology
Published: February 04, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026